Your shopping cart is empty

Subscriber login

Advanced Search

Home
Books
Conferences
DVDs
Newsletters
Form 483s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us

Check out our free and informative ezines and sign up now

Home > Newsletters > Drug GMP Report > Metal Contamination Concerns Land Tower Laboratories Form 483

Drug GMP Report

August 2012

Metal Contamination Concerns Land Tower Laboratories Form 483

Tower Laboratories, a contract manufacturer of OTC drugs, has received an FDA Form 483 for failure to fully investigate potential metal contamination of raw materials and finished products.

This article is viewable by subscribers only. To view this article, please select an option below.

Subscribe
Print This Page
RSS
Free Trial
Archives
Sample PDF

Novartis 483 Highlights Rocky Remediation at Nebraska Plant Concerns with Contract Manufacturer Draw Complete Response for Allergan’s Levadex Re-inspection of Hospira’s Rocky Mount Plant Prompts Fresh Form 483 Re-inspection of Hospira’s Rocky Mount Plant Prompts Fresh Form 483

Home
Advertising/Sponsorships
About Us
Contact Us
Site Map
Privacy Policy

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.